Table 2 Data sources
Data source | Description | Purpose |
|---|---|---|
Data abstraction | ▪ Data abstracted from clinical delivery tools | ▪ Define who is initiating PrEP and whether persons are appropriately put on PrEP |
Technical assistance | ▪ TA reports prepared at baseline and 6-monthly | ▪Document details of the process of adoption and integration of PrEP delivery and track changes in PrEP implementation processes. ▪ Rapid cycle analysis to convey to facilities for quality improvement |
Qualitative interviews: user and provider | ▪ Purposefully sampled patient and key informants involved in the delivery | ▪ Gain deep understanding of process of adoption and integration of PrEP delivery and track changes in PrEP implementation processes. |
Time and motion studies | ▪ Primary data collection | ▪ Economic evaluation |
Exit interviews | ▪ Random on spot user structured surveys at the end of clinic visit | ▪ User experiences and satisfaction |
Random blood draw | ▪ Dried blood spots collected at ~ 10% visits on persons using PrEP | ▪ Objective assessment of PrEP adherence (tenofovir levels), resistance surveillance |
Observation | ▪ Informal | ▪ Track changes in PrEP implementation processes. |